Proton Therapy Studies and Statistics

The medical community continues to conduct research studies on proton therapy. Provision and other medical centers are supporting many ongoing clinical trials and research initiatives to expand our knowledge of the most beneficial applications of proton therapy in treating cancer.

View the clinical benefits of proton therapy and read about peer review studies by clicking the type of cancer listed below.

Prostate Cancer

Clinical Benefits of Proton Therapy:

 

  • 4.9% higher overall 5 year survival rate.
  • 35% less radiation to bladder and 59% less radiation to the rectum.
  • Proton patients are almost twice as likely to report treatment had NO IMPACT on their quality of life compared to surgery, conventional radiation, and brachytherapy.
  • Half as many incidents of long term (2+ years) moderate or severe bowel problems.
  • 42% reduction in relative risk of developing a secondary malignancy.
  • Significantly fewer reports of gastrointestinal, genitourinary, endocrine, or “other” complications.
Sources and Studies:

 

Dose–Volume Comparison of Proton Therapy and Intensity-Modulated Radiotherapy for Prostate Cancer

Read More 

Comparative Effectiveness Study of Patient-Reported Outcomes following Proton Therapy or IMRT for Prostate Cancer

Read More 

Early Outcomes From Three Prospective Trials of Image-Guided Proton Therapy for Prostate Cancer

Read More 

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger

Read More 

Multi-Institutional Phase II Study of Proton Beam Therapy for Organ-Confined Prostate Cancer Focusing on the Incidence of Late Rectal Toxicities

Read More 

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95-09

Read More 

Patient-Reported Long-term Outcomes After Conventional and High-Dose Combined Proton and Photon Radiation for Early Prostate Cancer

Read More 

Proton Therapy Coverage for Prostate Cancer Treatment

Read More 

Breast Cancer

Clinical Benefits of Proton Therapy:

 

  • Delivers 8-18 times less overall radiation to the heart than IMRT
  • 50-83% less relative risk of heart attack or another major coronary event depending on age
  • 50% reduction of clinically significant radiation doses to the heart
  • 97% of partial breast irradiation patients experience no breast tumor recurrence at 5 years
  • 90% of cases result in good to excellent cosmetic outcomes at 5 years
Sources and Studies:

 

Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes

Read More 

Partial breast irradiation delivered with proton beam: results of a phase II trial

Read More 

A Technique of Partial Breast Irradiation Utilizing Proton Beam Radiotherapy: Comparison with Conformal X-Ray Therapy

Read More 

Accelerated partial breast irradiation using proton beams: Initial dosimetric experience

Read More 

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial

Read More 

Lung Cancer

Clinical Benefits of Proton Therapy:

 

  • 56% relative reduction in incidences of grade 3 esophagitis
  • 50% reduction in relative risk of recurrence
  • Higher radiation dose to the tumor while reducing risks of overall side effects
  • 64% relative increase in 5-year overall survival
Sources and Studies:

 

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer – Final Results of a Phase 2 Study

Read More 

The clinical case for proton beam therapy

Read More 

Brain/Head and Neck Cancers

Clinical Benefits of Proton Therapy:

 

  • 45% reduction in overall risk of needing a feeding tube for nasopharyngeal cancer
  • 27% reduction in overall risk of needing a feeding tube for oropharyngeal cancer
  • 44% increase of relative 5-year disease free survival rate for nasal and paranasal sinus cavity cancers
  • 50% overall increase of disease control for chordomas
  • Less side effects during first 3 months after treatment, quicker return to normal function
  • 50% less likely to have secondary tumor from treatment
Sources and Studies:

 

Proton Therapy Reduces Treatment Related Toxicities for Patients with Nasopharyngeal Cancer: A Case-Match Control Study of Intensity-Modulated Proton Therapy and Intensity-Modulated Photon Therapy

Read More 

Gastrostomy Tubes Decrease by Over 50% With Intensity Modulated Proton Therapy (IMPT) During the Treatment of Oropharyngeal Cancer Patients: A Case–Control Study

Read More 

Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis

Read More 

Effectiveness and Safety of Spot Scanning Proton Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base: First Long-Term Report

Read More 

Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Radiotherapy (IMRT) for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes

Read More 

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes

Read More 

Esophageal Cancer

Clinical Benefits of Proton Therapy:

 

  • 3 to 4-day reduction in average hospital stay
  • 5.1-22.8% overall reduction in pulmonary complications
  • 68% relative reduction in wound complications
Sources and Studies:

 

Radiation Modality Use and the Incidence of Postoperative Complications and Length of Hospitalization After Trimodality Therapy for Esophageal Cancer: A Multi-institutional Analysis

Read More 

Rectal/Anal Cancers

Clinical Benefits of Proton Therapy:

 

  • More than 50% reduction in radiation dose to critical structures including bone marrow
Sources and Studies:

 

Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer

Read More 

Current status and perspective of heavy ion beam therapy for patients with pelvic recurrence after primarily resected rectal cancer

Read More 

Liver Cancer (Hepatocellular)

Clinical Benefits of Proton Therapy:

 

  • 58% higher overall survival rate (2 years)
Sources and Studies:

 

The clinical benefits of proton therapy compared to conventional radiation treatments

Read More 

The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial

Read More 

Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma

Read More 

Bile Duct

Clinical Benefits of Proton Therapy:

 

  • 54% higher overall survival (4 years)
Sources and Studies:

 

The clinical benefits of proton therapy compared to conventional radiation treatments

Read More 

Central Nervous System (CNS) Cancers

Sources and Studies:

 

Phase I/II Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme

Read More 

Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas

Read More 

Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital

Read More 

Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis

Read More 

Proton beam therapy in the management of central nervous system tumors in childhood: the preliminary experience of the Centre de Protonthérapie d’Orsay

Read More 

Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial

Read More 

Ocular Malignancies and Benign Conditions

Sources and Studies:

 

The effectiveness and safety of proton radiation therapy for indications of the eye: a systematic review

Read More 

Proton beam irradiation for neovascular age-related macular degeneration

Read More 

Analysis of ocular surface alterations following proton beam radiation in eyes with conjunctival malignant melanoma

Read More 

Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison

Read More 

Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project)

Read More 

Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments

Read More 

Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial

Read More 

Thoracic Malignancies and Small Cell Lung Cancers

Sources and Studies:

 

Proton SBRT for medically inoperable stage I NSCLC

Read More 

Adaptive/Nonadaptive Proton Radiation Planning and Outcomes in a Phase II Trial for Locally Advanced Non-small Cell Lung Cancer

Read More 

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer

Read More 

Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer

Read More 

Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study

Read More 

High-dose proton beam therapy for Stage I non-small –cell lung cancer

Read More 

Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer

Read More 

Pancreatic Cancer

Sources and Studies:

 

Modern radiation therapy techniques for pancreatic cancer

Read More 

Treatment of locally advanced pancreatic cancer: the role of radiation therapy

Read More 

Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head

Read More 

The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors

Read More 

Bladder Malignancies

Sources and Studies:

 

A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study

Read More 

Cervical Malignancies

Sources and Studies:

 

Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries

Read More 

Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy

Read More 

Long-term results of proton beam therapy for carcinoma of the uterine cervix

Read More 

Bone Malignancies

Sources and Studies:

 

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase II study

Read More 

Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma

Read More 

Sarcomas (Soft Tissue)

Sources and Studies:

 

Heavy charged particle therapy of bone and soft tissue sarcoma. A phase I-II trial of the University of California Lawrence Berkeley Laboratory and the Northern California Oncology Group

Read More 

Pediatric Cancers and Malignancies

Sources and Studies:

 

Proton-Beam Therapy and Health-Related Quality of Life in Children With CNS Tumors

Read More 

Proton Radiotherapy for solid tumors of childhood

Read More 

Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of does characteristics and their relationship to cognitive function

Read More 

Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons

Read More 

Proton therapy in pediatric skull base and cervical canal low-grade bone malignancies

Read More 

Evaluation of propofol for repeated prolonged deep sedation in children undergoing proton radiation therapy

Read More 

Proton radiotherapy in management of pediatric base of skull tumors

Read More